Propanc Biopharma Inc (PPCB)

Jan 07, 2026

Propanc Biopharma Receives Nasdaq Minimum Bid Price Notice - TipRanks

Jan 07, 2026

Jan 07, 2026

Propanc Biopharma Received Notice of Noncompliance - TradingView — Track All Markets

Jan 07, 2026

Dec 30, 2025

Propanc Biopharma (NASDAQ: PPCB) details 2M-share Series C resale - Stock Titan

Dec 30, 2025

Dec 30, 2025

Propanc Biopharma files prospectus for resale of 2 million shares by selling stockholderSEC filing - MarketScreener

Dec 30, 2025

Dec 22, 2025

When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology - The Globe and Mail

Dec 22, 2025

Dec 22, 2025

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal - The Manila Times

Dec 22, 2025

Dec 22, 2025

Study tests enzyme mix that may disrupt deadly pancreatic tumors' support cells - Stock Titan

Dec 22, 2025

Dec 14, 2025

Propanc Biopharma, Inc. (PPCB) Stock Forecast & Price Prediction 2025–2030 - CoinCodex

Dec 14, 2025

Dec 06, 2025

Propanc Biopharma Shares Gain After Seeking Patent Protection for New Cancer and Fibrosis Treatments - MSN

Dec 06, 2025

Dec 05, 2025

Propanc Biopharma Inc. (PPCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 05, 2025

Dec 04, 2025

Propanc Biopharma, Inc. (PPCB) -6.3% in After-hours: Shares Slide Amid Investigation Announcement - Stocks Telegraph

Dec 04, 2025

Dec 04, 2025

Propanc Biopharma Investigates 'Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs - The Manila Times

Dec 04, 2025

Dec 04, 2025

Propanc Biopharma (Nasdaq: PPCB) targets fibrosis, cancer via PRP EMT research - Stock Titan

Dec 04, 2025

Dec 02, 2025

Views of Wall Street’s Leading Experts on Propanc Biopharma Inc - setenews.com

Dec 02, 2025

Dec 02, 2025

Propanc Biopharma (PPCB) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

Dec 01, 2025

Propanc Biopharma files patents for resistant cancer and fibrosis treatments By Investing.com - Investing.com Australia

Dec 01, 2025

Dec 01, 2025

Propanc Biopharma stock rises after filing for patents to treat resistant cancer By Investing.com - Investing.com South Africa

Dec 01, 2025

Dec 01, 2025

Propanc Biopharma stock rises after filing for patents to treat resistant cancer - Investing.com Australia

Dec 01, 2025

Dec 01, 2025

Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis - The Manila Times

Dec 01, 2025

Dec 01, 2025

Propanc Biopharma files patents for resistant cancer and fibrosis treatments - Investing.com

Dec 01, 2025

Dec 01, 2025

Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant ... - Enidnews.com

Dec 01, 2025

Dec 01, 2025

Propanc Biopharma (Nasdaq: PPCB) moves to patent PRP use in fibrosis ahead of 2026 Phase 1b trial - Stock Titan

Dec 01, 2025

Nov 26, 2025

Propanc Biopharma secures up to $100 million private placement - MSN

Nov 26, 2025

Nov 21, 2025

Propanc Biopharma Inc Share PricePPCB, RNS News, Articles, Quotes, & Charts (OTCMKTS:PPCB) - Proactive financial news

Nov 21, 2025

Nov 21, 2025

Australian firm launches crypto treasury for the future of cancer drug - Proactive financial news

Nov 21, 2025

Nov 17, 2025

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results - The Manila Times

Nov 17, 2025

Nov 17, 2025

Propanc Biopharma (Nasdaq: PPCB) Raises $4M, Lists on Nasdaq, Sets $100M Facility - Stock Titan

Nov 17, 2025

Nov 14, 2025

Propanc Biopharma, Inc. SEC 10-Q Report - TradingView

Nov 14, 2025

Nov 12, 2025

Propanc Biopharma Secures $1M Through Stock Sale - MSN

Nov 12, 2025

Nov 11, 2025

Propanc Biopharma Secures $100M Crypto Deal for Cancer Breakthrough - Analytics Insight

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma Secures Up to $100M to Build Crypto Treasury and Advance Cancer Therapy Trials - Bitget

Nov 11, 2025

Nov 11, 2025

The time has not yet come to remove your chips from the table: Propanc Biopharma Inc (PPCB) - setenews.com

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma (PPCB) Stock: Crypto Treasury Plan Triggers Massive Sell-Off - parameter.io

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma (PPCB) Stock: Biotech Secures $100M Crypto Funding as Shares Tumble - Blockonomi

Nov 11, 2025

Nov 11, 2025

Propanc, The Australian Biotech, Turns To Crypto To Tackle Cancer - Bitcoinist.com

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma (PPCB) Stock: Company Secures $100M Crypto Treasury Deal - CoinCentral

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma secures up to $100 million investment from Hexstone By Investing.com - Investing.com Nigeria

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma secures $1 million initial investment from Hexstone By Investing.com - Investing.com Nigeria

Nov 11, 2025

Nov 11, 2025

Propanc Biopharma Secures $100M to Build Crypto Treasury - Coinpaper

Nov 11, 2025

Nov 10, 2025

Bitcoin News Update: Propanc’s Cryptocurrency-Driven Cancer Initiative Encounters Doubt from Investors, Stock Falls by 10.5% - Bitget

Nov 10, 2025

Nov 10, 2025

Biopharma raises $100M for crypto treasury to back cancer treatment - TradingView

Nov 10, 2025

Nov 10, 2025

[8-K] Propanc Biopharma, Inc. Reports Material Event | PPCB SEC FilingForm 8-K - Stock Titan

Nov 10, 2025

Nov 10, 2025

Biotech firm Propanc lines up $100 million to fund crypto treasury and cancer therapy push - TradingView

Nov 10, 2025

Nov 10, 2025

Propanc Biopharma, Inc. announced that it has received $1 million in funding from Hexstone Capital, LLC - MarketScreener

Nov 10, 2025